Following update by GM clinicians and discussion at the September meeting of CRG, we now seek comments on several draft guidelines and position statements. To take part in any of these consultations, visit the consultations page.
DOAC commissioning statement
We now seek comments on a draft commissioning statement on Direct Oral Anticoagulants (DOACs), including positioning of apixaban and rivaroxaban. This consultation will run for two weeks and closes at 5pm on Monday 7th October 2024..
Palliative Care Pain and Symptom Control Guidelines for Adults
Following review and update by the Greater Manchester Integrated Palliative and End of Life Care Strategic Group, we now seek comments on the updated draft Greater Manchester Palliative Care Pain & Symptom Control Guidelines for Adults. This consultation will run for six weeks and closes at 5pm on Monday 4th November 2024.
Pylera position statement
On behalf of the antimicrobial working group, we now seek comments on a draft position statement relating to bismuth / metronidazole / tetracycline capsules (Pylera). This consultation will run for six weeks and closes at 5pm on Monday 4th November 2024.
To take part in either consultation, visit the consultations page.